BioMedical SIG #8

BioMedical SIG #8

Join us for the final webinar in the BioMedical SIG series: The Regulatory Path from Academic Drug Discovery to Market Authorisation Application.

Book Your Place

This event has now expired

Many drugs start life in academia. However, limited understanding of the drug development path and more specifically of regulatory aspects that should be considered hinder progress. This session will provide an overview of the regulatory path for medicines and how it aligns and feeds into the design of pre-clinical, non-clinical, clinical and quality (chemistry, manufacturing, control – CMC) studies that are necessary for preparing a clinical trial submission and ultimately a marketing authorization application. Critical concept will be discussed that academic researchers or early-stage entrepreneurs must be aware and which can help support progressing their drug development work, accessing funding and building partnerships.

This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.

Booking Options

  • Are you an ASTP Member?

  • By proceeding with this booking, you are agreeing to allow ASTP to use your image solely for promotional and educational purposes.

Testimonials

testimonial

From day one ASTP has been a tremendous help. Learning throughs seminars and workshops or meeting peers for discussions, there is always someone around to exchange ideas with.

Paul van Dun

KU Leuven, Belgium

testimonial

Fruitful discussion.

Cecile Henrich-Burkhardt

Technical University of Munich, Germany

testimonial

It is always encouraging to see that other TTOs are encountering the same problems that we do!

Aurore De Boom

Université Libré de Bruxelle, Belgium

testimonial

Great atmosphere to learn and to share experiences.

Maria Ruiz Novales

Interface-Enterprises - University of Liege, Belgium

testimonial

Excellent professional gathering, perfect collection of topics and very up-to-date insight.

Ludovic Urgeghe

University of Mons, Belgium